On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a ...

Oneview Healthcare today introduced Ovie, an innovative new GenAI product that provides personalized, real-time support for patients and families throughout their hospital stay.

Lower functionality scores among older female rheumatic patients highlight the need for patient education ... or previously participated in an online health program (2/126; 1.6%). Usability and data ...

The Bilateral Indigenous Patient ... The program is intended to improve Indigenous patient access and experiences when accessing the primary health care system by: supporting the provision of cultural ...

and the new headwind in the form of Medicare Part D benefit design which represents an additional headwind AbbVie needs to absorb. The pipeline is also progressing nicely. There are five new ...

Shares of AbbVie (NYSE: ABBV) were jumping 7.1% higher as of 11:10 a.m. ET on Friday after rising as much as 9.2% earlier in the day. The nice gain stemmed from the big drugmaker's 2024 fourth ...

AbbVie reported its 2024 Q4 results on Friday. Investors especially liked the drugmaker's 2025 outlook. AbbVie reported Q4 net revenue of $15.1 billion, up 5.6% and higher than the average ...

a Represents net earnings attributable to AbbVie Inc. Intangible asset impairment primarily reflects partial impairment charges related to the U.S. Imbruvica and CoolSculpting intangible assets.

AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit ...

The patient must have six months or less to live ... When asked about people who think dying with medical assistance isn't a great idea, Goodfriend said, "If it's not a good idea for you, don ...